KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Debt Ratio (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of Debt Ratio data on record, last reported at 0.46 in Q4 2025.

  • For Q4 2025, Debt Ratio fell 9.63% year-over-year to 0.46; the TTM value through Dec 2025 reached 0.46, down 9.63%, while the annual FY2025 figure was 0.46, 9.63% down from the prior year.
  • Debt Ratio reached 0.46 in Q4 2025 per JAZZ's latest filing, down from 0.47 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.55 in Q3 2022 and bottomed at 0.27 in Q1 2021.
  • Average Debt Ratio over 5 years is 0.49, with a median of 0.5 recorded in 2023.
  • The widest YoY moves for Debt Ratio: up 71.71% in 2021, down 11.18% in 2021.
  • A 5-year view of Debt Ratio shows it stood at 0.49 in 2021, then grew by 7.4% to 0.53 in 2022, then fell by 5.09% to 0.5 in 2023, then increased by 1.42% to 0.51 in 2024, then decreased by 9.63% to 0.46 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.46 in Q4 2025, 0.47 in Q3 2025, and 0.49 in Q2 2025.